Johnson & Johnson shares were off more than 2per cent on Wednesday, a day after a U.S. jury said it must pay US$8 billion in punitive damages to a plaintiff in a case involving its anti-psychotic drug Risperdal, a penalty the company and others are confident will not stand.

More...